Crinetics Pharmaceuticals, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSan Diego, CA
SAM.gov UEIMJZFLM2TGRZ8
Crinetics Pharmaceuticals discovers and develops medicines for endocrinology. The company's pipeline includes Paltusotine, an oral SST2 agonist; Atumelnant, an oral ACTH antagonist; and CRN09682, a nonpeptide drug conjugate. Vertex Pharmaceuticals has agreed to acquire the company.
Summarized from the company’s own website
Their plants
2 FACILITIES| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Crinetics Pharmaceuticals INC | San Diego | CA | — | UNVERIFIED |
| Crinetics Pharmaceuticals, INC | San Diego | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.